Lv2
160 积分 2023-08-17 加入
In vitro and in vivo comparison of eravacycline- and tigecycline-based combination therapies for tigecycline-resistant Acinetobacter baumannii
2天前
已完结
Exploring the Impact of Pharmacological Target-Mediated Low Plasma Exposure in Lead Compound Selection in Drug Discovery – A Modeling Approach
2天前
已完结
Physiologically based pharmacokinetic modeling of ponatinib to describe drug–drug interactions in patients with cancer
2天前
已完结
In Vitro Assessment of Inhibitory Effects of Kinase Inhibitors on CYP2C9, 3A and 1A2: Prediction of Drug-Drug Interaction Risk with Warfarin and Direct Oral Anticoagulants
3天前
已完结
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
9天前
已完结
Physiologically based pharmacokinetic combined JAK2 occupancy modelling to simulate PK and PD of baricitinib with kidney transporter inhibitors and in patients with hepatic/renal impairment
10天前
已完结
Application of physiologically based pharmacokinetics modeling in the research of small-molecule targeted anti-cancer drugs
19天前
已完结
Application of Physiologically Based Pharmacokinetic Modeling in Understanding Bosutinib Drug-Drug Interactions: Importance of Intestinal P-Glycoprotein
24天前
已关闭
Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug–Drug and Drug–Disease Interactions
24天前
已完结
Application of physiologically based pharmacokinetics modeling in the research of small-molecule targeted anti-cancer drugs
1个月前
已完结
皖公网安备34019202002308
